Recommendations for the use of influenza vaccine in pediatrics

Susanna Esposito, Valentina Montinaro, Samantha Bosis, Claudia Tagliabue, Elena Baggi, Nicola Principi

Research output: Contribution to journalArticle

Abstract

Every year for the last few decades, the health authorities of most countries throughout the world have issued specific recommendations for the prevention and treatment of pediatric influenza, including recommendations concerning the use of vaccines. However, different evaluations of the importance of the disease and the efficacy of influenza vaccination frequently lead to conflicting recommendations. This is clearly demonstrated not only by the differences in the subjects for whom the vaccine is recommended, but also by the inaccurate manner in which subjects at risk of influenzarelated complications are defined. Only further studies that consider the burden of the disease and vaccine efficacy in adequate numbers of healthy children and high-risk children with different chronic underlying diseases can overcome all of the current limitations and significantly improve vaccination coverage in both categories.

Original languageEnglish
Pages (from-to)42-46
Number of pages5
JournalHuman Vaccines and Immunotherapeutics
Volume8
Issue number1
DOIs
Publication statusPublished - Jan 2012

Fingerprint

Influenza Vaccines
Vaccines
Pediatrics
Human Influenza
Vaccination
Chronic Disease
Health
Therapeutics

Keywords

  • Children
  • Influenza
  • Influenza vaccination
  • Influenza vaccines
  • Pediatrics

ASJC Scopus subject areas

  • Immunology
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Recommendations for the use of influenza vaccine in pediatrics. / Esposito, Susanna; Montinaro, Valentina; Bosis, Samantha; Tagliabue, Claudia; Baggi, Elena; Principi, Nicola.

In: Human Vaccines and Immunotherapeutics, Vol. 8, No. 1, 01.2012, p. 42-46.

Research output: Contribution to journalArticle

Esposito, Susanna ; Montinaro, Valentina ; Bosis, Samantha ; Tagliabue, Claudia ; Baggi, Elena ; Principi, Nicola. / Recommendations for the use of influenza vaccine in pediatrics. In: Human Vaccines and Immunotherapeutics. 2012 ; Vol. 8, No. 1. pp. 42-46.
@article{1bd0f914e657413583b6b6ab6516fb7f,
title = "Recommendations for the use of influenza vaccine in pediatrics",
abstract = "Every year for the last few decades, the health authorities of most countries throughout the world have issued specific recommendations for the prevention and treatment of pediatric influenza, including recommendations concerning the use of vaccines. However, different evaluations of the importance of the disease and the efficacy of influenza vaccination frequently lead to conflicting recommendations. This is clearly demonstrated not only by the differences in the subjects for whom the vaccine is recommended, but also by the inaccurate manner in which subjects at risk of influenzarelated complications are defined. Only further studies that consider the burden of the disease and vaccine efficacy in adequate numbers of healthy children and high-risk children with different chronic underlying diseases can overcome all of the current limitations and significantly improve vaccination coverage in both categories.",
keywords = "Children, Influenza, Influenza vaccination, Influenza vaccines, Pediatrics",
author = "Susanna Esposito and Valentina Montinaro and Samantha Bosis and Claudia Tagliabue and Elena Baggi and Nicola Principi",
year = "2012",
month = "1",
doi = "10.4161/hv.8.1.17957",
language = "English",
volume = "8",
pages = "42--46",
journal = "Human Vaccines and Immunotherapeutics",
issn = "2164-5515",
publisher = "Taylor and Francis Inc.",
number = "1",

}

TY - JOUR

T1 - Recommendations for the use of influenza vaccine in pediatrics

AU - Esposito, Susanna

AU - Montinaro, Valentina

AU - Bosis, Samantha

AU - Tagliabue, Claudia

AU - Baggi, Elena

AU - Principi, Nicola

PY - 2012/1

Y1 - 2012/1

N2 - Every year for the last few decades, the health authorities of most countries throughout the world have issued specific recommendations for the prevention and treatment of pediatric influenza, including recommendations concerning the use of vaccines. However, different evaluations of the importance of the disease and the efficacy of influenza vaccination frequently lead to conflicting recommendations. This is clearly demonstrated not only by the differences in the subjects for whom the vaccine is recommended, but also by the inaccurate manner in which subjects at risk of influenzarelated complications are defined. Only further studies that consider the burden of the disease and vaccine efficacy in adequate numbers of healthy children and high-risk children with different chronic underlying diseases can overcome all of the current limitations and significantly improve vaccination coverage in both categories.

AB - Every year for the last few decades, the health authorities of most countries throughout the world have issued specific recommendations for the prevention and treatment of pediatric influenza, including recommendations concerning the use of vaccines. However, different evaluations of the importance of the disease and the efficacy of influenza vaccination frequently lead to conflicting recommendations. This is clearly demonstrated not only by the differences in the subjects for whom the vaccine is recommended, but also by the inaccurate manner in which subjects at risk of influenzarelated complications are defined. Only further studies that consider the burden of the disease and vaccine efficacy in adequate numbers of healthy children and high-risk children with different chronic underlying diseases can overcome all of the current limitations and significantly improve vaccination coverage in both categories.

KW - Children

KW - Influenza

KW - Influenza vaccination

KW - Influenza vaccines

KW - Pediatrics

UR - http://www.scopus.com/inward/record.url?scp=84857214946&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857214946&partnerID=8YFLogxK

U2 - 10.4161/hv.8.1.17957

DO - 10.4161/hv.8.1.17957

M3 - Article

AN - SCOPUS:84857214946

VL - 8

SP - 42

EP - 46

JO - Human Vaccines and Immunotherapeutics

JF - Human Vaccines and Immunotherapeutics

SN - 2164-5515

IS - 1

ER -